Chronic pain often goes unrecognized and untreated in individuals with Alzheimer's disease and related dementias (ADRD), mainly due to limited capacity to verbalize pain. Addressing this issue requires the development of reliable objective biomarkers for pain. In the present pilot study, we explored the feasibility and acceptability of using a wearable electroencephalograph (EEG) and a screen-based eye tracker system to identify neural signatures of chronic pain in this population. First, we developed a multimodality biomedical signal acquisition setup with four parts: hardware to record biomedical signals, software to monitor and synchronize multiple inputs, an experimental paradigm with resting state and a cognitive task to assess pain, and an online database to collect subject demographics and subjective measures in a secure environment. EEG signals were recorded using an FDA-cleared 32-channel EEG device with 3-axis accelerometer while gaze and pupil dilation were captured via a head-free, video-based eye tracker. A cognitive task was designed using 32 custom-generated images representing pain/no-pain conditions in addition to 16 images with painful and neuter expressions from the Delaware Pain Database. EEGs, accelerometer, and eye tracker data were synchronized with the behavioral paradigm by sending digital triggers from paradigm module on a MATLAB/Simulink model that was designed for the study. Finally, a database was created on RedCap with 16 separate instruments from cognitive and pain assessment tools to the feasibility and acceptability surveys.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884661 | PMC |
http://dx.doi.org/10.1109/EMBC53108.2024.10782487 | DOI Listing |
Eur J Phys Rehabil Med
March 2025
Rehabilitation Medicine Center, The Second Affiliated Hospital of Wenzhou Medical University, Zhejiang, China -
Background: Sedentary behavior (SB) is associated with chronic musculoskeletal pain, but limited evidence exists about its impact on chronic spinal pain (CSP).
Aim: This study aims to explore the relationship between SB, physical activity, and the risk of CSP.
Design: Cross-sectional and cohort study design.
Eur J Phys Rehabil Med
March 2025
Department of Physical Medicine and Rehabilitation, CHU Nimes, University of Montpellier, Nimes, France.
Background: Impaired body perception could contribute to the pain experience and be a possible treatment target. The Fremantle Back Awareness Questionnaire (FreBAQ) is the only self-report questionnaire to assess back-specific self-perception.
Aim: The aim of this study was to develop a French version of the FreBAQ (FreBAQ-FR) and to evaluate its psychometric properties.
Am J Chin Med
March 2025
School of Public Health, Nantong University, 9 Seyuan Road, Nantong, Jiangsu 226019, P. R. China.
Ulcerative colitis (UC) is a chronic, nonspecific inflammatory disorder characterized by symptoms such as abdominal pain, diarrhea, hematochezia, and urgency during defecation. While the primary site of involvement is the colon, UC can extend to encompass the entire rectum and colon. The causes and development mechanisms of UC are still not well understood; nonetheless, it is currently held that factors including environmental influences, genetic predispositions, intestinal mucosal integrity, gut microbiota composition, and immune dysregulation contribute to its development.
View Article and Find Full Text PDFFront Immunol
March 2025
Rheumatology Unit, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint pain, swelling, and stiffness, affecting approximately 1% of the adult population. Tocilizumab (TCZ), a monoclonal antibody targeting the IL-6 receptor, has emerged as an effective treatment for RA. This narrative review provides an update on TCZ's efficacy and safety based on data from randomized controlled trials (RCTs) and real-world evidence (RWE).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!